Cosmetic cross-reference

Silicon Dioxide

CAS 7631-86-9

Silicon Dioxide (CAS 7631-86-9) is a pharmaceutical compound with 0 bioactivity targets and 464 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral / FAERS
Adverse signals
464
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE DrugCentral 2023 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Silicon Dioxide
CAS Number
7631-86-9
UNII
ETJ7Z6XBU4
InChIKey
VYPSYNLAJGMNEJ-UHFFFAOYSA-N
ChEMBL ID
CHEMBL2108563
Source Match
DrugCentral (CAS), FDA GSRS (UNII)
Synonyms and normalized names
SILICASANDCOLLOIDAL SILICON DIOXIDESILICON DIOXIDE, COLLOIDAL
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 2023 / FAERS disproportionality 41 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Febrile neutropenia 165 165.169 10016288
Myelosuppression 65 114.246 10028584
Platelet count decreased 114 91.556 10035528
Hepatic function abnormal 69 87.571 10019670
Respiratory tract infection bacterial 19 65.978 10060693
Respiratory tract infection viral 19 50.453 10062106
Exposure to toxic agent 22 50.343 10053487
Neutrophil count decreased 53 43.296 10029366
Acute myeloid leukaemia 33 42.208 10000880
CADASIL 6 31.77 10065555
Liver disorder 41 31.185 10024670
Physical examination abnormal 7 29.016 10062078
Visual evoked potentials abnormal 6 27.721 10047549
Cytokine release syndrome 25 26.438 10052015
Saccadic eye movement 6 25.904 10053694
Magnetic resonance imaging spinal abnormal 6 24.457 10083139
Drug intolerance 5 23.603 10061822
White blood cell count decreased 62 23.471 10047942
Lipid metabolism disorder 6 23.145 10061227
Drug ineffective 78 23.064 10013709
Central nervous system inflammation 6 22.558 10051288
Cerebral microangiopathy 6 22.415 10067466
Off label use 56 22.255 10053762
Double stranded DNA antibody positive 6 20.901 10069907
Skin lesion 26 20.555 10040882
Anaemia 105 20.343 10002034
Bronchopulmonary aspergillosis 18 19.459 10006473
Pyrexia 141 19.309 10037660
Atrioventricular conduction time shortened 3 18.704 10068180
Pneumonia 141 18.479 10035664
Pneumonia fungal 13 17.886 10061354
Respiratory tract infection 26 17.792 10062352
Creatinine renal clearance increased 6 17.433 10011364
Sepsis 71 16.828 10040047
Bone marrow failure 25 16.587 10065553
CSF protein increased 6 16.405 10011575
Laryngeal inflammation 4 16.201 10065735
Electrocardiogram QT prolonged 33 16.129 10014387
Joint stiffness 23 15.829 10023230
Renal disorder 24 15.79 10038428
Blast cell count increased 6 15.135 10062274

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE RxNorm drug names 10 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
SILICA 9771 SU MTHSPL
SAND 9771 SU MTHSPL
SILICON DIOXIDE 9771 SU MTHSPL
Silicon Dioxide 9771 SU MTHSPL
Silicon dioxide 9771 SU MTHSPL
silicon dioxide 9771 SU MTHSPL
COLLOIDAL SILICON DIOXIDE 314826 SU MTHSPL
SILICON DIOXIDE, COLLOIDAL 314826 SU MTHSPL
colloidal silicon dioxide 314826 SU MTHSPL
silicon dioxide 9771 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Silicon Dioxide used for in pharmaceutical contexts?

Silicon Dioxide (CAS 7631-86-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Silicon Dioxide?

Silicon Dioxide has 464 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Febrile neutropenia, Myelosuppression, Platelet count decreased, Hepatic function abnormal, Respiratory tract infection bacterial. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Silicon Dioxide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Hydrolyzed Silica with EU status "permitted".

What clinical phase is Silicon Dioxide in?

No phase 1-4 clinical development badge is rendered for Silicon Dioxide because the matched compound identifier rows do not contain a max-phase value.